Jennison Associates’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-51,334
| Closed | -$1.05M | – | 637 |
|
|
2024
Q2 | $1.05M | Buy |
51,334
+1,164
| +2% | +$23.9K | ﹤0.01% | 484 |
|
|
2024
Q1 | $1.19M | Sell |
50,170
-610
| -1% | -$14.5K | ﹤0.01% | 485 |
|
|
2023
Q4 | $1.1M | Sell |
50,780
-2,296,893
| -98% | -$49.6M | ﹤0.01% | 484 |
|
|
2023
Q3 | $34.1M | Sell |
2,347,673
-174,243
| -7% | -$2.53M | 0.03% | 238 |
|
|
2023
Q2 | $52.8M | Buy |
2,521,916
+105,462
| +4% | +$2.21M | 0.04% | 185 |
|
|
2023
Q1 | $51M | Buy |
2,416,454
+114,208
| +5% | +$2.41M | 0.05% | 180 |
|
|
2022
Q4 | $58.6M | Buy |
2,302,246
+652,451
| +40% | +$16.6M | 0.06% | 167 |
|
|
2022
Q3 | $39.6M | Buy |
+1,649,795
| New | +$39.6M | 0.04% | 208 |
|
|
2018
Q1 | – | Sell |
-531,028
| Closed | -$4.65M | – | 693 |
|
|
2017
Q4 | $4.65M | Sell |
531,028
-420,870
| -44% | -$3.69M | ﹤0.01% | 498 |
|
|
2017
Q3 | $11.1M | Sell |
951,898
-1,964
| -0.2% | -$23K | 0.01% | 469 |
|
|
2017
Q2 | $13.3M | Buy |
+953,862
| New | +$13.3M | 0.01% | 450 |
|
|
2017
Q1 | – | Sell |
-93,783
| Closed | -$672K | – | 768 |
|
|
2016
Q4 | $672K | Sell |
93,783
-289,993
| -76% | -$2.08M | ﹤0.01% | 637 |
|
|
2016
Q3 | $5.82M | Sell |
383,776
-153,769
| -29% | -$2.33M | 0.01% | 500 |
|
|
2016
Q2 | $5.25M | Buy |
537,545
+76,653
| +17% | +$748K | 0.01% | 486 |
|
|
2016
Q1 | $5.98M | Buy |
+460,892
| New | +$5.98M | 0.01% | 476 |
|